On 30-Mar-2020, Sanofi announced that "The first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara® (sarilumab)...
On 02-April-2020, "Amgen and Adaptive technologies announced a collaboration aimed at helping address the COVID-19 pandemic.
The companies will combine expertise to discover and develop...
On 03-April-2020, The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19.
As...
On 30-Mar-2020, AstraZeneca announced that "its Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung...
On 28-Mar-2020, AstraZeneca announced that "new data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure)...
On 30-Mar-2020, AstraZeneca announced that "The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for Farxiga (dapagliflozin) in patients with chronic kidney disease (CKD) will be stopped...
On 26-Mar-2020, SK Biopharmaceuticals Co., Ltd. announced the "European Medicines Agency (EMA) acceptance of Arvelle Therapeutics' Marketing Authorization Application (MAA) for cenobamate, an...
On 27-Mar-2020, Sanofi announced that "The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sarclisa®...
On 27-Mar-2020, "Abbott has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fastest available molecular point-of-care test...
On 26-Mar-2020, Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture and delivery of vaccines,...
COVID-19: The full form of this disease is Coronavirus Infectious Disease 2019 which is caused by Coronavirus.
Coronavirus: It's named that because it has...